Management of iatrogenic colonic endoscopic: the endoscopist point of view
Frédérick Moryoussef , Arnaud Saget , Sarah Leblanc , Gilles Manceau
Hépato-Gastro & Oncologie Digestive 23 ( 5) 392 -401
2016
Management of iatrogenic colonic endoscopic perforation: the surgical point of view
Arnaud Saget , Frédérick Moryoussef , Sarah Leblanc , Yann Le Baleur
Hépato-Gastro & Oncologie Digestive 23 ( 5) 402 -410
2016
Rectal localization of hereditary colorectal cancer syndromes: what medico-surgical management in daily practice?
Frédérick Moryoussef , Mehdi Karoui , Jean-Baptiste Bachet , Chrystelle Colas
Hépato-Gastro & Oncologie Digestive 23 ( 3) 263 -272
2016
Prognostic value of high c-Met expression in patients with poor prognosis pancreatic adenocarcinoma following surgical resection: comparison of three c-Met scoring methods and exploration of underlying mechanisms of c-Met overexpression
Cindy Neuzillet , Annemilaï Tijeras-Raballand , Jérôme Raffenne , Armand de Gramont
Cancer Research 75 ( 15_Supplement) 794 -794
2015
c-Met overexpression as an independent prognostic biomarker and therapeutic target in patients with poor prognostic pancreatic adenocarcinoma following surgical resection
Cindy Neuzillet , Jerome Cros , Annemilai Tijeras-Raballand , Armand De Gramont
CANCER RESEARCH 75
2015
La rédaction d’Acta Endoscopica remercie chaleureusement les experts qui ont accepté de relire et commenter les articles originaux publiés dans la revue en 2014. Isabelle Trouilloud Philippe Bulois
Geoffroy Vanvberlviet , Denis Heresbach , Jean-Baptiste Bachet , Christian Boustière
Acta Endosc 45 86 -86
2015
c-MET as a prognostic biomarker and therapeutic target in patients with poor prognostic pancreatic adenocarcinoma following surgical resection
Cindy Neuzillet , Jerome Cros , Annemilaï Tijeras-Raballand , Julien Moroch
Cancer Research 74 ( 19_Supplement) 3824 -3824
2014
c-MET as a target for MET inhibitors in patients with poor prognostic pancreatic adenocarcinoma following completed surgical resection
Cindy Neuzillet , Jerome Cros , Annemilai Tijeras-Raballand , Julien Moroch
MOLECULAR CANCER THERAPEUTICS 12 ( 11)
2013
Prevalence of Carcinoid Heart Disease Increases During Follow-Up
Nicolas Mansencal , Emmanuel Mitry , Jean-Baptiste Bachet , Philippe Rougier
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 53 ( 10) A409 -A409
2009
Dysfonction de l'anastomose porto-systémique en cas de syndrome de Budd-Chiari: retentissement sur la survie à long terme et facteurs prédictifs de sa survenue
Jean-Baptiste Bachet
2005
LIF drives neural remodeling in pancreatic cancer and offers a new candidate biomarker.
Samuel Granjeaud , Jean-Baptiste Bachet , Mehdi Ouaissi , Juan Iovanna
Research and Reviews: Journal of Pharmaceutical Research and Clinical Practice
Gérard Milano , Marie-Christine Etienne-Grimaldi , Laurence Llorca , Patricia Formento
BRAF mutation is not associated with an increased risk of recurrence in patients undergoing resection of colorectal liver metastases
J.‐B. Bachet , N. Moreno‐Lopez , L. Vigano , U. Marchese
British Journal of Surgery 106 ( 9) 1237 -1247
11
2019
PEPCOL: a GERCOR randomized phase II study of nanoliposomal irinotecan PEP02 (MM‐398) or irinotecan with leucovorin/5‐fluorouracil as second‐line therapy in metastatic colorectal cancer
Benoist Chibaudel , Frédérique Maindrault‐Gœbel , Jean‐Baptiste Bachet , Christophe Louvet
Cancer Medicine 5 ( 4) 676 -683
32
2016
Folliculitis Induced by EGFR Inhibitors, Preventive and Curative Efficacy of Tetracyclines in the Management and Incidence Rates According to the Type of EGFR Inhibitor Administered: A Systematic Literature Review
Jean‐Baptiste Bachet , Lucie Peuvrel , Claude Bachmeyer , Ziad Reguiai
Oncologist 17 ( 4) 555 -568
44
2012
Impact on health‐related quality of life deterioration‐free survival of a first‐line therapy combining nab‐paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil for patients with metastatic pancreatic cancer: Results of the randomized phase II AFUGEM GERCOR clinical trial
Emilie Charton , Jean‐Baptiste Bachet , Pascal Hammel , Jérôme Desramé
Cancer Medicine 8 ( 11) 5079 -5088
4
2019
Panitumumab-based maintenance after oxaliplatin discontinuation in metastatic colorectal cancer: A retrospective analysis of two randomised trials.
Dominik Paul Modest , Fernando Rivera , Jean‐Baptiste Bachet , Filippo Braud
International Journal of Cancer 145 ( 2) 576 -585
5
2019
Management of biliary tract cancers in early‐onset patients: A nested multicenter retrospective study of the ACABI GERCOR PRONOBIL cohort
Antoine Lebeaud , Leony Antoun , Jane‐Rose Paccard , Julien Edeline
Liver International
2024
Efficacy of aflibercept with FOLFOX and maintenance with fluoropyrimidine as first‑line therapy for metastatic colorectal cancer: GERCOR VELVET phase II study.
Benoist Chibaudel , Jean‑Baptiste Bachet , Thierry Andr� , Dominique Auby
International Journal of Oncology 54 ( 4) 1433 -1445
6
2019
Levels of Gemcitabine Transport and Metabolism Proteins Predict Survival Times of Patients Treated With Gemcitabine for Pancreatic Adenocarcinoma
Raphaël Maréchal , Jean–Baptiste Bachet , John R Mackey , Cécile Dalban
Gastroenterology 143 ( 3) 664 -674.e6
178
2012